These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 631464)
41. Frequency of a normal lung scan observed in the urokinase-streptokinase pulmonary embolism trial. Hull RD; Raskob GE Invest Radiol; 1987 Apr; 22(4):357. PubMed ID: 3583658 [No Abstract] [Full Text] [Related]
42. [Fibrinolytic therapy and anticoagulation. Pediatric experience]. Hostalot Abás A; Palomeque Rico A; Pastor Durán X An Esp Pediatr; 1997 Sep; 47(3):315-8. PubMed ID: 9499287 [No Abstract] [Full Text] [Related]
43. [Thrombolysis with Urokinase after anaphylaxis caused by streptokinase treatment (author's transl)]. Walter B; Tamm D Med Klin; 1979 Feb; 74(7):239-41. PubMed ID: 763216 [TBL] [Abstract][Full Text] [Related]
44. [Value of Lysyl-plasminogen-urokinase sequential treatment in thrombolytic therapy]. Brochier M; Planiol T; Griguer P; Raynaud P; Fauchier JP; Charbonnier B; Latour F; Pellois A Coeur Med Interne; 1977; 16(4):513-21. PubMed ID: 589966 [No Abstract] [Full Text] [Related]
45. [Biochemistry and clinical significance of urokinase]. Andrassy K; Ritz E Dtsch Med Wochenschr; 1978 Jun; 103(24):1011, 1015-20. PubMed ID: 350536 [No Abstract] [Full Text] [Related]
46. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases]. Verstraete M Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864 [No Abstract] [Full Text] [Related]
47. [Thrombolytic therapy in massive pulmonary embolism]. Brandis S; Catz M; Rechnitz J; Appelman I; Zahavi I Harefuah; 1986 Mar; 110(6):285-8. PubMed ID: 3732935 [No Abstract] [Full Text] [Related]
48. [Treatment of severe pulmonary embolism by the in situ injection of urokinase]. Giard A; Pauchant M Nouv Presse Med; 1978 Dec; 7(44):4050. PubMed ID: 733578 [No Abstract] [Full Text] [Related]
50. Streptokinase and urokinase in the treatment of pulmonary thromboemboli; from a national cooperative study. Bell WR Thromb Haemost; 1976 Feb; 35(1):57-69. PubMed ID: 785689 [TBL] [Abstract][Full Text] [Related]
52. [Pulmonary embolism: what happens to the emboligenic focus?]. Serradimigni A; Philip F; Elias A; Lecorff G Haemostasis; 1986; 16 Suppl 4():69-78. PubMed ID: 3770559 [No Abstract] [Full Text] [Related]
53. Urokinase i and ii activity. Samama M; Cazenave B; Otero AM Thromb Haemost; 1979 Feb; 40(3):578-80. PubMed ID: 425074 [No Abstract] [Full Text] [Related]
54. Clinical use of thrombolytic agents in venous thromboembolism. Sasahara AA; Sharma GV; Tow DE; McIntyre KM; Parisi AF; Cella G Arch Intern Med; 1982 Apr; 142(4):684-8. PubMed ID: 7073411 [TBL] [Abstract][Full Text] [Related]
55. [Thrombolysis in acute massive lung embolism]. Marbet GA Schweiz Med Wochenschr; 1988 Aug; 118(31-32):1138-41. PubMed ID: 3175566 [TBL] [Abstract][Full Text] [Related]
60. [Fibrinolytic therapy of deep venous thromboses. Prevention of post-thrombotic syndrome in the area of the pelvis and leg]. Theiss W Fortschr Med; 1986 Aug; 104(30):575-8. PubMed ID: 3758885 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]